The analysis of the impact of intestinal flora and metabolic product on development of chronic liver disease

The analysis of the impact of intestinal flora and metabolic product on development of chronic liver disease - The analysis of the impact of intestinal flora and metabolic product on development of chronic liver disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029607

Enrollment

200

Registered

2017-10-19

Start date

2017-05-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic liver disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who are 20 years of age or older at the time of obtaining informed consent 2. Patients who are informed and have provided written informed consent to participate in the study prior to study initiation

Exclusion criteria

Exclusion criteria: 1. Patients with severe liver dysfunction 2. Patients by whom principal investigator has determined to inapproprtiate as a subject

Design outcomes

Primary

Measure	Time frame
metagenome analysis of intestinal flora	—

Countries

Japan

Contacts

Public ContactGoki Suda

Hokkaido University Hospital Department of Gastroenterology and Hepatology

gsudgast@pop.med.hokudai.ac.jp011-716-1161

Outcome results